Recommendations and Guidelines:

ACIP Presentation Slides: June 2009 Meeting

June 24, 2009

Welcome

• Opening Remarks (1 page, 21 KB)
  Dr. L Pickering

General Recommendations

• Combination vaccines; Special situations; Vaccination records (51 pages, 341 KB)
  Dr. A Kroger

Rabies Vaccines

• Reduced rabies vaccine schedule (post-exposure prophylaxis)
  (20 pages, 224 KB)
  Dr. C Rupprecht
  
  

Poliovirus Vaccines

• Introduction (7 pages, 285 KB)
  Dr. L Chilton
  
• Poliovirus Eradication Program in India, 2009 (7 pages, 1882 KB)
  Mr. R Beck
  
• Updated recommendations for routine poliovirus immunization (10 pages, 274 KB)
  Dr. G Wallace
  
• Update VFC vote (5 pages, 100 KB)
  Dr. J Santoli
  

Measles, Mumps and Rubella Vaccine

• Proposed changes to current evidence of immunity requirements for MMR vaccination for Healthcare personnel (51 pages, 603 KB)
  Dr. K Gallagher
  

Human Papillomavirus (HPV) Vaccines

• Introduction (7 pages, 38 KB)
  Dr. J Englund
• Quadrivalent HPV vaccine (16 pages, 66 KB)
  Dr. R Haupt
• Overview of cost-effectiveness models of male vaccination (29 pages, 343 KB)
  Dr. H Chesson
• Issues and potential recommendation options: vaccination of males (23 pages, 109 KB)
  Dr. L Markowitz

Meningococcal Vaccine

• Overview of Work Group Activities (8 pages, 36 KB)
  Dr. C Baker
• Update: new meningococcal conjugate vaccine (MenACYW-CRW) (16 pages, 321 KB)
  Dr. P Dull
• Estimate of Effectiveness of Meningococcal Conjugate Vaccine (MCV4) (25 pages, 140 KB)
  Ms. J MacNeil
• Recommendations for MCV4 revaccination for persons at prolonged increased risk for meningococcal disease (25 pages, 171 KB)
  Dr. A Cohn
• Update VFC vote (7 pages, 109 KB)
  Dr. J Santoli

Japanese Encephalitis (JE) Vaccine

• Introduction & Revised JE vaccine recommendations (45 pages, 483 KB)
  Dr. P Cieslak
  Dr. M Fischer

Hepatitis Vaccines

• Introduction & Hepatitis B in long-term care residents and the role of vaccination (36 pages, 248 KB)
  Dr. M Sawyer
  Dr. N Thompson
  

Yellow Fever (YF) Vaccine

• Update: Yellow Fever Vaccine Work Group & Proposed updates to the ACIP YF vaccine recommendations (20 pages, 281 KB)
  Dr. C Baker
  Dr. E Staples

June 25, 2009

Haemophilus influenzae B (Hib) Vaccine

• Introduction: overview of session (3 page, 91 KB)
  Dr. A Shefer
• GSK monovalent Hib vaccine (12 page, 181 KB)
  Dr. R Abu-Elazeed (GSK)
• Hib surveillance (10 page, 89 KB)
  Dr. M Jackson
• Hib vaccine supply (3 page, 42 KB)
  Dr. J Santoli
• Hib vaccine implementation plan (11 page, 110 KB)
  Dr. A Shefer

Vaccine Supply

• Update: Vaccine Supply (9 page, 165 KB)
  Dr. J Santoli

Measles-Mumps-Rubella-Varicella (MMRV) Vaccine Safety

• Introduction (12 page, 253 KB)
  Dr. J Temte
• Parental perceptions of MMRV vaccine (21 page, 135 KB)
  Mr. A Janssen
• Evaluation of MMRV and Febrile seizures: VSD expanded chart review study (29 page, 136 KB)
  Dr. N Klien (Kaiser Permanente)
• Synthesis of safety evidence for MMRV vaccine and febrile seizure risk (57 page, 202 KB)
  Dr. K Broder
• Synthesis of analytic framework for MMRV vaccine policy options; options for recommendations (45 page, 157 KB)
  Dr. M Marin
• Update VFC vote (9 page, 119 KB)
  Dr. J Santoli

Role of Pharmacists in Vaccine Administration

• Role of Pharmacists (17 page, 596 KB)
  Dr. S Foster (ACIP Liaison American Pharmacists Association)

Influenza

• Session introduction & overview (8 pages, 36 KB)
  Dr. K Neuzil
  Dr. A Fiore
• 2008-2009 influenza epidemiology; seasonal and novel influenza A (H1N1) (26 pages, 447 KB)
  Dr. L Finelli
• Influenza antiviral medications (24 pages, 304 KB)
  Dr. A Fiore
• Novel Influenza A (H1N1) vaccine development and progress
  Dr. R Robinson (BARDA) (7 pages, 157 KB)
  Dr. N Baylor (FDA) (8 pages, 164 KB)
  Dr. G Curlin (NIH) (12 pages, 414 KB)
  Dr. B Gellin (NVPO) (6 pages, 191 KB)
  
• Review of existing vaccine prioritization guidance (13 pages, 273 KB)
  Dr. T Shimabukuros

June 26, 2009

Novel Influenza A (H1N1)

• Virology and immunology (19 pages, 950 KB)
  Dr. N Cox
• Vaccine program implementation plans (15 pages, 67 KB)
  Dr. P Wortley
• Review of planned vaccine effectiveness studies
  Dr. D Shay (12 pages, 60 KB)
  Dr. J Sanchez (29 pages, 2518 KB)
  
• Review of influenza vaccine safety monitoring plans (21 pages, 91 KB)
  Dr. C Weinbaum
• Summary of issues and wrap up of session (6 pages, 30 KB)
  Dr. K Neuzil
  Dr. A Fiore
  

Pneumococcal Vaccines

• Session overview (12 pages, 16 KB)
  Dr. M Marcy
• Planning for use of PPSV23 to prevent novel influenza A (H1N1) – associated pneumococcal disease (18 pages, 16 KB)
  Dr. M Moore
• Invasive pneumococcal disease burden caused by PCV13 serotypes (29 pages, 16 KB)
  Dr. P Nuorti

.pdf files: To view and print the .pdf files on this site, you will need Adobe Acrobat Reader. Use this link to obtain a free copy of Adobe Acrobat Reader (exit). We highly recommend that you upgrade to the latest version if haven't already.

*Accessibility Note: For text-only versions of these files for screen-reader device compatibility, contact NIPINFO@cdc.gov for immediate assistance.

 Return to main ACIP page

• Email this page
• Printer-friendly version

• Help
• Glossary / Acronyms
• Site Map